Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide
Pharmaceutics · 02.08.2024 · 16 (8) · 1036
DOI: 10.3390/pharmaceutics16081036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 02.08.2024. Verfasst von Rubén Gil-Gonzalo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pluridisciplinar Institute, Complutense University of Madrid, Paseo Juan XXIII, 1, E-28040 Madrid, Spain. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Innovation and Universities Ministry, Spain, Programa Investigo, Science, Innovation and Universities Ministry.
Abstract (Originalsprache)
Cancer and bacterial infections rank among the most significant global health threats. accounting for roughly 25 million fatalities each year. This statistic underscores the urgent necessity for developing novel drugs, enhancing current treatments, and implementing systems that boost their bioavailability to achieve superior therapeutic outcomes. Liposomes have been recognised as effective carriers; nonetheless, they encounter issues with long-term stability and structural integrity, which limit their pharmaceutical applicability. Chitosomes (chitosan-coated liposomes) are generally a good alternative to solve these issues. This research aims to demonstrate the effective individual encapsulation of ciprofloxacin (antibacterial, hydrophilic) and etoposide (anticancer, hydrophobic), within chitosomes to create more effective drug delivery systems (oral administration for ciprofloxacin, parenteral administration for etoposide). Thus, liposomes and chitosomes were prepared using the thin-film hydration technique and were characterised through ATR-FTIR, Dynamic Light Scattering (DLS), zeta potential, and release profiling. In both cases, the application of chitosomes enhanced long-term stability in size and surface charge. Chitosome-encapsulated ciprofloxacin formulations exhibited a slower and sustained release profile, while the combined effect of etoposide and chitosan showed heightened efficacy against the glioblastoma cell line U373. Therefore, coating liposomes with chitosan improved the encapsulation system’s properties, resulting in a promising method for drug delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pluridisciplinar Institute, Complutense University of Madrid, Paseo Juan XXIII, 1, E-28040 Madrid, Spain.
- Department of Chemistry in Pharmaceutical Science, Pharmacy Faculty, Complutense University of Madrid, Plaza de Ramón y Cajal s/n, E-28040 Madrid, Spain.
- Neural Regeneration Group, Hospital Nacional de Parapléjicos (SESCAM), E-45071 Toledo, Spain.
ORCID-Profile: Rubén Gil-Gonzalo, D Alonzo Durante-Salmerón, Ernesto Doncel-Pérez, Andrés R Alcántara, Inmaculada Aranaz, Niuris Acosta
Förderung
- Science, Innovation and Universities Ministry, Spain
- Programa Investigo
- Science, Innovation and Universities Ministry
Zitieren
APA
Gil-Gonzalo, R., Durante-Salmerón, D. A., Pouri, S., Doncel-Pérez, E., Alcántara, A. R., Aranaz, I., & Acosta, N. (2024). Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide. Pharmaceutics, 16(8), 1036. https://doi.org/10.3390/pharmaceutics16081036
Vancouver
Gil-Gonzalo R, Durante-Salmerón DA, Pouri S, Doncel-Pérez E, Alcántara AR, Aranaz I, et al. Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide. Pharmaceutics. 2024;16(8):1036. doi:10.3390/pharmaceutics16081036
BibTeX
@article{GilGonzalo2024,
author = {Gil-Gonzalo, Rubén and Durante-Salmerón, D Alonzo and Pouri, Saeedeh and Doncel-Pérez, Ernesto and Alcántara, Andrés R and Aranaz, Inmaculada and Acosta, Niuris},
title = {Chitosan-Coated Liposome Formulations for Encapsulation of Ciprofloxacin and Etoposide},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {8},
pages = {1036},
doi = {10.3390/pharmaceutics16081036}
}
EUVIMED